Donald Bellgrau - Publications

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Immunology, Cell Biology, Genetics

50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Modiano JF, Lindborg BA, McElmurry RT, Lewellen M, Forster CL, Zamora EA, Schaack J, Bellgrau D, O'Brien TD, Tolar J. Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment. Cancer Immunology, Immunotherapy : Cii. 64: 1449-60. PMID 26250807 DOI: 10.1007/S00262-015-1749-6  0.324
2014 King TH, Kemmler CB, Guo Z, Mann D, Lu Y, Coeshott C, Gehring AJ, Bertoletti A, Ho ZZ, Delaney W, Gaggar A, Subramanian GM, McHutchison JG, Shrivastava S, Lee YJ, ... ... Bellgrau D, et al. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. Plos One. 9: e101904. PMID 25051027 DOI: 10.1371/Journal.Pone.0101904  0.366
2014 May SL, Zhou Q, Lewellen M, Carter CM, Coffey D, Highfill SL, Bucher CM, Matise I, Morse HC, O'Sullivan MG, Schutten M, Johnson C, Bellgrau D, Blazar BR, Modiano JF. Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis. Plos One. 9: e100629. PMID 24945807 DOI: 10.1371/Journal.Pone.0100629  0.526
2012 Tamburini BA, Kedl RM, Bellgrau D. IL-6-inducing whole yeast-based immunotherapy directly controls IL-12-dependent CD8 T-cell responses. Journal of Immunotherapy (Hagerstown, Md. : 1997). 35: 14-22. PMID 22130158 DOI: 10.1097/Cji.0B013E3182356888  0.37
2009 Jubala CM, Lamerato-Kozicki AR, Borakove M, Lang J, Gardner LA, Coffey D, Helm KM, Schaack J, Baier M, Cutter GR, Bellgrau D, Modiano JF. MHC-dependent desensitization of intrinsic anti-self reactivity. Cancer Immunology, Immunotherapy : Cii. 58: 171-85. PMID 18523772 DOI: 10.1007/S00262-008-0535-0  0.5
2008 Modiano JF, Johnson LD, Bellgrau D. Negative regulators in homeostasis of naïve peripheral T cells. Immunologic Research. 41: 137-53. PMID 18415030 DOI: 10.1007/S12026-008-8017-1  0.43
2007 Kupfer R, Lang J, Williams-Skipp C, Nelson M, Bellgrau D, Scheinman RI. Loss of a gimap/ian gene leads to activation of NF-kappaB through a MAPK-dependent pathway. Molecular Immunology. 44: 479-87. PMID 16584774 DOI: 10.1016/J.Molimm.2006.02.014  0.507
2005 Jubala CM, Wojcieszyn JW, Valli VE, Getzy DM, Fosmire SP, Coffey D, Bellgrau D, Modiano JF. CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma. Veterinary Pathology. 42: 468-76. PMID 16006606 DOI: 10.1354/Vp.42-4-468  0.345
2004 Lang JA, Kominski D, Bellgrau D, Scheinman RI. Partial activation precedes apoptotic death in T cells harboring an IAN gene mutation. European Journal of Immunology. 34: 2396-406. PMID 15307172 DOI: 10.1002/Eji.200324751  0.563
2004 Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D, Modiano JF. Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells. The Journal of Pharmacology and Experimental Therapeutics. 311: 758-69. PMID 15231866 DOI: 10.1124/Jpet.104.070060  0.368
2004 Modiano JF, Sun J, Lang J, Vacano G, Patterson D, Chan D, Franzusoff A, Gianani R, Meech SJ, Duke R, Bellgrau D. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells. Clinical Immunology (Orlando, Fla.). 112: 54-65. PMID 15207782 DOI: 10.1016/J.Clim.2004.03.011  0.49
2002 Lang J, Bellgrau D. A T-cell functional phenotype common among autoimmune-prone rodent strains. Scandinavian Journal of Immunology. 55: 546-59. PMID 12028557 DOI: 10.1046/J.1365-3083.2002.01086.X  0.569
2001 Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D, Franzusoff A, Duke RC, Wilson CC. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nature Medicine. 7: 625-9. PMID 11329066 DOI: 10.1038/87974  0.434
2001 Moore JK, Scheinman RI, Bellgrau D. The identification of a novel T cell activation state controlled by a diabetogenic gene. Journal of Immunology (Baltimore, Md. : 1950). 166: 241-8. PMID 11123298 DOI: 10.4049/Jimmunol.166.1.241  0.728
1999 Moore JK, Gold DP, Dreskin SC, Lernmark A, Bellgrau D. A diabetogenic gene prevents T cells from receiving costimulatory signals. Cellular Immunology. 194: 90-7. PMID 10357884 DOI: 10.1006/Cimm.1999.1501  0.737
1999 Moore JK, Bellgrau D. Promiscuous activation and cell cycle entry in T cells from autoimmune animals. Transplantation Proceedings. 31: 1606-10. PMID 10331020 DOI: 10.1016/S0041-1345(99)00056-1  0.719
1999 Duke RC, Newell E, Schleicher M, Meech S, Bellgrau D. Transplantation of cells and tissues expressing Fas ligand. Transplantation Proceedings. 31: 1479-81. PMID 10330975 DOI: 10.1016/S0041-1345(99)00012-3  0.395
1997 Gold DP, Shaikewitz ST, Mueller D, Redd JR, Sellins KS, Pettersson A, Lernmark A, Bellgrau D. T cells from BB-DP rats show a unique cytokine mRNA profile associated with the IDDM1 susceptibility gene, Lyp. Autoimmunity. 22: 149-61. PMID 8734569 DOI: 10.3109/08916939508995312  0.62
1996 Bellgrau D, Stenger D, Richards C, Bao F. The diabetic BB rat. Neither Th1 nor Th2? Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 28: 299-301. PMID 8811334 DOI: 10.1055/S-2007-979798  0.53
1996 Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection European Journal of Gastroenterology & Hepatology. 8: 95. DOI: 10.1097/00042737-199601000-00020  0.675
1996 Duke RC, Franzusoff A, Bellgrau D. CD95 ligand in graft rejection Nature. 379: 682-683. DOI: 10.1038/379682B0  0.329
1995 Fleshner M, Bellgrau D, Watkins LR, Laudenslager ML, Maier SF. Stress-induced reduction in the rat mixed lymphocyte reaction is due to macrophages and not to changes in T cell phenotypes. Journal of Neuroimmunology. 56: 45-52. PMID 7822481 DOI: 10.1016/0165-5728(94)00132-8  0.468
1995 Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature. 377: 630-2. PMID 7566174 DOI: 10.1038/377630A0  0.702
1994 Bellgrau D, Redd JM, Sellins KS. Peculiar T-cell signaling does not preclude positive selection in the diabetes-prone BB rat. Diabetes. 43: 47-52. PMID 8262316 DOI: 10.2337/Diab.43.1.47  0.608
1994 Kruse CA, Schiltz PM, Bellgrau D, Kong Q, Kleinschmidt-DeMasters BK. Intracranial administrations of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumors. Journal of Neuro-Oncology. 19: 161-8. PMID 7964992 DOI: 10.1007/Bf01306458  0.321
1994 Fleshner M, Watkins LR, Redd JM, Kruse CA, Bellgrau D. A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats. Cell Transplantation. 1: 307-12. PMID 1344303 DOI: 10.1177/096368979200100408  0.358
1993 Kruse CA, Mitchell DH, Kleinschmidt-DeMasters BK, Bellgrau D, Eule JM, Parra JR, Kong Q, Lillehei KO. Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma. Journal of Neuro-Oncology. 15: 97-112. PMID 8509824 DOI: 10.1007/Bf01053931  0.357
1993 Fleshner M, Watkins LR, Lockwood LL, Bellgrau D, Laudenslager ML, Maier SF. Specific changes in lymphocyte subpopulations: a potential mechanism for stress-induced immunomodulation. Journal of Neuroimmunology. 41: 131-42. PMID 1469075 DOI: 10.1016/0165-5728(92)90063-Q  0.39
1992 Sellins KS, Bellgrau D, Gold DP. Specificity of rat T cell receptor V beta chain usage in proliferative responses to staphylococcal enterotoxin B. European Journal of Immunology. 22: 1931-4. PMID 1385576 DOI: 10.1002/Eji.1830220738  0.428
1992 Redd JM, Lagarde AC, Kruse CA, Bellgrau D. Allogeneic tumor-specific cytotoxic T lymphocytes. Cancer Immunology, Immunotherapy : Cii. 34: 349-54. PMID 1371720 DOI: 10.1007/Bf01741557  0.423
1991 Kruse CA, Lillehei KO, Mitchell DH, Kleinschmidt-DeMasters B, Bellgrau D. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take. Proceedings of the National Academy of Sciences of the United States of America. 87: 9577-81. PMID 2263613 DOI: 10.1073/Pnas.87.24.9577  0.489
1991 Gold DP, Bellgrau D. Identification of a limited T-cell receptor beta chain variable region repertoire associated with diabetes in the BB rat. Proceedings of the National Academy of Sciences of the United States of America. 88: 9888-91. PMID 1658791 DOI: 10.1073/PNAS.88.21.9888  0.407
1990 Babcock SK, Niswender K, Wilson DB, Bellgrau D. Cyclosporine-induced autoimmunity in rats carrying thymus allografts. Transplantation. 50: 278-81. PMID 2382294 DOI: 10.1097/00007890-199008000-00022  0.329
1990 Bellgrau D, Selawry HP. Cyclosporine-induced tolerance to intratesticular islet xenografts. Transplantation. 50: 654-7. PMID 2219288 DOI: 10.1097/00007890-199010000-00025  0.343
1990 Bellgrau D, Lagarde AC. Cytotoxic T-cell precursors with low-level CD8 in the diabetes-prone Biobreeding rat: implications for generation of an autoimmune T-cell repertoire. Proceedings of the National Academy of Sciences of the United States of America. 87: 313-7. PMID 2104982 DOI: 10.1073/Pnas.87.1.313  0.633
1989 Georgiou HM, Bellgrau D. Persistent immunogenicity of rat thymic epithelium. Transplantation. 48: 302-6. PMID 2526972 DOI: 10.1097/00007890-198908000-00023  0.349
1988 Georgiou HM, Lagarde AC, Bellgrau D. T cell dysfunction in the diabetes-prone BB rat. A role for thymic migrants that are not T cell precursors. The Journal of Experimental Medicine. 167: 132-48. PMID 2961842 DOI: 10.1084/Jem.167.1.132  0.59
1988 McAteer MJ, Lagarde AC, Georgiou HM, Bellgrau D. A requirement for the CD5 antigen in T cell activation. European Journal of Immunology. 18: 1111-7. PMID 2456937 DOI: 10.1002/Eji.1830180721  0.61
1988 Bellgrau D, Walker TA, Cook JL. Recognition of adenovirus E1A gene products on immortalized cell surfaces by cytotoxic T lymphocytes Journal of Virology. 62: 1513-1519. PMID 2451753 DOI: 10.1128/JVI.62.5.1513-1519.1988  0.365
1986 Bellgrau D, Talmage DW. T cells can be cytotoxic without making interleukin 2: a model of separate pathways of induction. Proceedings of the National Academy of Sciences of the United States of America. 83: 3412-6. PMID 2939451 DOI: 10.1073/PNAS.83.10.3412  0.325
1985 Bellgrau D, Lagarde AC. In vivo separation of two classes of T cells as determined by negative selection after the injection of UV-treated allogeneic lymphoid cells. Proceedings of the National Academy of Sciences of the United States of America. 82: 5136-9. PMID 3875095 DOI: 10.1073/Pnas.82.15.5136  0.471
1985 HODGKIN PD, AGOSTINO M, SELLINS K, PROWSE SJ, BELLGRAU D, LAFFERTY KJ. T LYMPHOCYTE FUNCTION IN VIVO Transplantation. 40: 288-292. DOI: 10.1097/00007890-198509000-00014  0.476
1983 Naji A, Bellgrau D, Anderson A, Silvers WK, Barker CF. Transplantation of islets and bone marrow cells to animals with immune insulitis. Diabetes. 84-91. PMID 6819968 DOI: 10.2337/Diab.31.4.S84  0.39
1983 Bellgrau D. Induction of cytotoxic T cell precursors in vivo. Role of T helper cells. The Journal of Experimental Medicine. 157: 1505-15. PMID 6222131 DOI: 10.1084/JEM.157.5.1505  0.471
1983 Bellgrau D, Naji A, Silvers WK, Markmann JF, Barker CF. Spontaneous diabetes in BB rats: evidence for a T cell dependent immune response defect. Diabetologia. 23: 359-64. PMID 6216134 DOI: 10.1007/Bf00253745  0.423
1982 Zöller M, Bellgrau D, Axberg I, Wigzell H. Natural killer cells do not belong to the recirculating lymphocyte population. Scandinavian Journal of Immunology. 15: 159-67. PMID 6179152 DOI: 10.1111/j.1365-3083.1982.tb00634.x  0.46
1981 Bellgrau D, Smilek D, Wilson DB. Induced tolerance in F1 rats to anti-major histocompatibility complex receptors on parental T cells. Implications for self tolerance. The Journal of Experimental Medicine. 153: 1660-5. PMID 6973003 DOI: 10.1084/Jem.153.6.1660  0.386
1981 Naji A, Silvers WK, Bellgrau D, Barker CF. Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance. Science (New York, N.Y.). 213: 1390-2. PMID 6791286 DOI: 10.1126/Science.6791286  0.35
1979 Bellgrau D, Wilson DB. Immunological studies of T-cell receptors. II. Limited polymorphism of idiotype determinants on T-cell receptors specific for major histocompatibility complex alloantigens Journal of Experimental Medicine. 149: 234-243. PMID 33224 DOI: 10.1084/jem.149.1.234  0.422
1978 Bellgrau D, Wilson DB. Immunological studies of T-cell receptors. I. Specifically induced resistance to graft-versus-host disease in rats mediated by host T-cell immunity to alloreactive parental T cells Journal of Experimental Medicine. 148: 103-114. PMID 78954 DOI: 10.1084/jem.148.1.103  0.427
Show low-probability matches.